Reston, VA (February 10, 2026)-- The Society of Nuclear Medicine and Molecular Imaging announced today that Ken Herrmann, MD, MBA, has been selected as the next editor-in-chief of The Journal of Nuclear Medicine (JNM). Herrmann will begin a five-year term on January 1, 2027, with a transition period beginning July 1, 2026.
Recognized as one of the world s top medical imaging journals, JNM ranks seventh among 212 journals in the medical imaging category, according to Clarivate s Journal Citation Reports . The journal is an essential global resource in nuclear medicine, molecular imaging and theranostics.
Herrmann will succeed Johannes Czernin, MD, professor and vice chair of the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. During his 10-year tenure as editor-in-chief, Czernin guided JNM through a period of significant growth, strengthening its scientific rigor while expanding its global reach and influence across the medical imaging field.
Currently chair of nuclear medicine at the University of Duisburg-Essen in Germany, Herrmann brings more than two decades of international leadership in nuclear medicine and theranostics. His background spans clinical expertise, translational research and strategic management, with experience in Europe, North America and Asia. He practiced for almost a decade in the United States at Memorial Sloan Kettering Cancer Center in New York and at the University of California in Los Angeles.
Trained in medicine in Germany, Herrmann completed a nuclear medicine residency in Munich and earned an MBA from the University of Zurich. He has authored more than 700 publications and is a long-time contributor and associate editor for JNM.
"JNM stands at a pivotal moment, as academic publishing, global research collaboration and digital communication continue to evolve at an unprecedented pace," Herrmann said. "As editor-in-chief, I am committed to strengthening JNM's global engagement and impact ensuring the journal reflects the full breadth of scientific excellence, diversity and leadership across all continents."
A full announcement detailing Herrmann's vision and editorial priorities will be released on July 1.
###
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world s leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 30 million times each year by practitioners around the globe. Visit JNM at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging and theranostics precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.